Zacks Investment Research cut shares of CRH Medical (NYSEAMERICAN:CRHM) from a hold rating to a sell rating in a research note released on Tuesday.

According to Zacks, “CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O’Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I – IV. It distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians. The company utilizes Web-based platform to connect doctors with patients as well as educating its install base of physicians. It also offers anesthesia services. CRH Medical Corporation is headquartered in Vancouver, Canada. “

Separately, TheStreet upgraded CRH Medical from a c rating to a b- rating in a research note on Friday, August 24th.

Shares of CRH Medical stock opened at $3.66 on Tuesday. CRH Medical has a 12 month low of $2.15 and a 12 month high of $4.50.

Institutional investors and hedge funds have recently modified their holdings of the business. ClariVest Asset Management LLC purchased a new position in shares of CRH Medical in the third quarter valued at $154,000. Acadian Asset Management LLC purchased a new position in shares of CRH Medical in the third quarter valued at $354,000. Wedge Capital Management L L P NC purchased a new position in shares of CRH Medical in the third quarter valued at $373,000. CIBC World Markets Inc. purchased a new position in shares of CRH Medical in the second quarter valued at $722,000. Finally, Ativo Capital Management LLC grew its position in shares of CRH Medical by 7.1% in the third quarter. Ativo Capital Management LLC now owns 300,079 shares of the company’s stock valued at $1,185,000 after purchasing an additional 20,002 shares in the last quarter.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Featured Story: What is a Market Correction?

Get a free copy of the Zacks research report on CRH Medical (CRHM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.